世界の高血圧治療薬（高血圧症）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global High Blood Pressure Drugs (Hypertension) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z06918 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、高血圧治療薬（高血圧症）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。高血圧治療薬（高血圧症）の種類別市場規模（ACEI、CCB、ARB）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・高血圧治療薬（高血圧症）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly、Pfizer、Bayer、Symplmed、Novartis、Merck、Sanofi、Boryung、Reata Pharmaceuticals、Lung Biotechnology、Yuhan、Takeda、Alvogen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ACEI、CCB、ARB ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・高血圧治療薬（高血圧症）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・高血圧治療薬（高血圧症）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・高血圧治療薬（高血圧症）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・高血圧治療薬（高血圧症）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・高血圧治療薬（高血圧症）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The High Blood Pressure Drugs (Hypertension) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global High Blood Pressure Drugs (Hypertension) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global High Blood Pressure Drugs (Hypertension) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
High Blood Pressure Drugs (Hypertension) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
ACEI
CCB
ARB

Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

The key market players for global High Blood Pressure Drugs (Hypertension) market are listed below:
Eli Lilly
Pfizer
Bayer
Symplmed
Novartis
Merck
Sanofi
Boryung
Reata Pharmaceuticals
Lung Biotechnology
Yuhan
Takeda
Alvogen

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 High Blood Pressure Drugs (Hypertension) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global High Blood Pressure Drugs (Hypertension) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 ACEI
1.2.3 CCB
1.2.4 ARB
1.3 Market Analysis by Application
1.3.1 Overview: Global High Blood Pressure Drugs (Hypertension) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global High Blood Pressure Drugs (Hypertension) Market Size & Forecast
1.4.1 Global High Blood Pressure Drugs (Hypertension) Sales in Value (2016-2026))
1.4.2 Global High Blood Pressure Drugs (Hypertension) Sales in Volume (2016-2026)
1.4.3 Global High Blood Pressure Drugs (Hypertension) Price by Type (2016-2026) & (USD/MT)
1.5 Global High Blood Pressure Drugs (Hypertension) Production Capacity Analysis
1.5.1 Global High Blood Pressure Drugs (Hypertension) Total Production Capacity (2016-2026)
1.5.2 Global High Blood Pressure Drugs (Hypertension) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 High Blood Pressure Drugs (Hypertension) Market Drivers
1.6.2 High Blood Pressure Drugs (Hypertension) Market Restraints
1.6.3 High Blood Pressure Drugs (Hypertension) Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly High Blood Pressure Drugs (Hypertension) Product and Services
2.1.4 Eli Lilly High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer High Blood Pressure Drugs (Hypertension) Product and Services
2.2.4 Pfizer High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer High Blood Pressure Drugs (Hypertension) Product and Services
2.3.4 Bayer High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Symplmed
2.4.1 Symplmed Details
2.4.2 Symplmed Major Business
2.4.3 Symplmed High Blood Pressure Drugs (Hypertension) Product and Services
2.4.4 Symplmed High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis High Blood Pressure Drugs (Hypertension) Product and Services
2.5.4 Novartis High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck High Blood Pressure Drugs (Hypertension) Product and Services
2.6.4 Merck High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi High Blood Pressure Drugs (Hypertension) Product and Services
2.7.4 Sanofi High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Boryung
2.8.1 Boryung Details
2.8.2 Boryung Major Business
2.8.3 Boryung High Blood Pressure Drugs (Hypertension) Product and Services
2.8.4 Boryung High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Reata Pharmaceuticals
2.9.1 Reata Pharmaceuticals Details
2.9.2 Reata Pharmaceuticals Major Business
2.9.3 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Product and Services
2.9.4 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Lung Biotechnology
2.10.1 Lung Biotechnology Details
2.10.2 Lung Biotechnology Major Business
2.10.3 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Product and Services
2.10.4 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Yuhan
2.11.1 Yuhan Details
2.11.2 Yuhan Major Business
2.11.3 Yuhan High Blood Pressure Drugs (Hypertension) Product and Services
2.11.4 Yuhan High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business
2.12.3 Takeda High Blood Pressure Drugs (Hypertension) Product and Services
2.12.4 Takeda High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Alvogen
2.13.1 Alvogen Details
2.13.2 Alvogen Major Business
2.13.3 Alvogen High Blood Pressure Drugs (Hypertension) Product and Services
2.13.4 Alvogen High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 High Blood Pressure Drugs (Hypertension) Sales by Manufacturer
3.1 Global High Blood Pressure Drugs (Hypertension) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in High Blood Pressure Drugs (Hypertension)
3.4 Market Concentration Rate
3.4.1 Top 3 High Blood Pressure Drugs (Hypertension) Manufacturer Market Share
3.4.2 Top 6 High Blood Pressure Drugs (Hypertension) Manufacturer Market Share
3.5 Global High Blood Pressure Drugs (Hypertension) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and High Blood Pressure Drugs (Hypertension) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global High Blood Pressure Drugs (Hypertension) Market Size by Region
4.1.1 Global High Blood Pressure Drugs (Hypertension) Sales in Volume by Region (2016-2026)
4.1.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Region (2016-2026)
4.2 North America High Blood Pressure Drugs (Hypertension) Revenue (2016-2026)
4.3 Europe High Blood Pressure Drugs (Hypertension) Revenue (2016-2026)
4.4 Asia-Pacific High Blood Pressure Drugs (Hypertension) Revenue (2016-2026)
4.5 South America High Blood Pressure Drugs (Hypertension) Revenue (2016-2026)
4.6 Middle East and Africa High Blood Pressure Drugs (Hypertension) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global High Blood Pressure Drugs (Hypertension) Sales in Volume by Type (2016-2026)
5.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Type (2016-2026)
5.3 Global High Blood Pressure Drugs (Hypertension) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global High Blood Pressure Drugs (Hypertension) Sales in Volume by Application (2016-2026)
6.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Application (2016-2026)
6.3 Global High Blood Pressure Drugs (Hypertension) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America High Blood Pressure Drugs (Hypertension) Sales by Type (2016-2026)
7.2 North America High Blood Pressure Drugs (Hypertension) Sales by Application (2016-2026)
7.3 North America High Blood Pressure Drugs (Hypertension) Market Size by Country
7.3.1 North America High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2016-2026)
7.3.2 North America High Blood Pressure Drugs (Hypertension) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe High Blood Pressure Drugs (Hypertension) Sales by Type (2016-2026)
8.2 Europe High Blood Pressure Drugs (Hypertension) Sales by Application (2016-2026)
8.3 Europe High Blood Pressure Drugs (Hypertension) Market Size by Country
8.3.1 Europe High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2016-2026)
8.3.2 Europe High Blood Pressure Drugs (Hypertension) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales by Type (2016-2026)
9.2 Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales by Application (2016-2026)
9.3 Asia-Pacific High Blood Pressure Drugs (Hypertension) Market Size by Region
9.3.1 Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific High Blood Pressure Drugs (Hypertension) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America High Blood Pressure Drugs (Hypertension) Sales by Type (2016-2026)
10.2 South America High Blood Pressure Drugs (Hypertension) Sales by Application (2016-2026)
10.3 South America High Blood Pressure Drugs (Hypertension) Market Size by Country
10.3.1 South America High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2016-2026)
10.3.2 South America High Blood Pressure Drugs (Hypertension) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales by Type (2016-2026)
11.2 Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales by Application (2016-2026)
11.3 Middle East & Africa High Blood Pressure Drugs (Hypertension) Market Size by Country
11.3.1 Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa High Blood Pressure Drugs (Hypertension) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 High Blood Pressure Drugs (Hypertension) Typical Distributors
12.3 High Blood Pressure Drugs (Hypertension) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global High Blood Pressure Drugs (Hypertension) Revenue by Type, (USD Million), 2021-2026
Table 2. Global High Blood Pressure Drugs (Hypertension) Revenue by Application, (USD Million), 2021-2026
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly High Blood Pressure Drugs (Hypertension) Product and Services
Table 6. Eli Lilly High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer High Blood Pressure Drugs (Hypertension) Product and Services
Table 10. Pfizer High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer High Blood Pressure Drugs (Hypertension) Product and Services
Table 14. Bayer High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Symplmed Basic Information, Manufacturing Base and Competitors
Table 16. Symplmed Major Business
Table 17. Symplmed High Blood Pressure Drugs (Hypertension) Product and Services
Table 18. Symplmed High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis High Blood Pressure Drugs (Hypertension) Product and Services
Table 22. Novartis High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck High Blood Pressure Drugs (Hypertension) Product and Services
Table 26. Merck High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi High Blood Pressure Drugs (Hypertension) Product and Services
Table 30. Sanofi High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Boryung Basic Information, Manufacturing Base and Competitors
Table 32. Boryung Major Business
Table 33. Boryung High Blood Pressure Drugs (Hypertension) Product and Services
Table 34. Boryung High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Reata Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Reata Pharmaceuticals Major Business
Table 37. Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Product and Services
Table 38. Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Lung Biotechnology Basic Information, Manufacturing Base and Competitors
Table 40. Lung Biotechnology Major Business
Table 41. Lung Biotechnology High Blood Pressure Drugs (Hypertension) Product and Services
Table 42. Lung Biotechnology High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Yuhan Basic Information, Manufacturing Base and Competitors
Table 44. Yuhan Major Business
Table 45. Yuhan High Blood Pressure Drugs (Hypertension) Product and Services
Table 46. Yuhan High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Takeda Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Major Business
Table 49. Takeda High Blood Pressure Drugs (Hypertension) Product and Services
Table 50. Takeda High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Alvogen Basic Information, Manufacturing Base and Competitors
Table 52. Alvogen Major Business
Table 53. Alvogen High Blood Pressure Drugs (Hypertension) Product and Services
Table 54. Alvogen High Blood Pressure Drugs (Hypertension) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global High Blood Pressure Drugs (Hypertension) Sales by Manufacturer (2019-2021e) & (K MT)
Table 56. Global High Blood Pressure Drugs (Hypertension) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in High Blood Pressure Drugs (Hypertension), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global High Blood Pressure Drugs (Hypertension) Production Capacity by Company, (K MT): 2020 VS 2021
Table 59. Head Office and High Blood Pressure Drugs (Hypertension) Production Site of Key Manufacturer
Table 60. Global High Blood Pressure Drugs (Hypertension) Sales by Region (2016-2021e) & (K MT)
Table 61. Global High Blood Pressure Drugs (Hypertension) Sales by Region (2021-2026) & (K MT)
Table 62. Global High Blood Pressure Drugs (Hypertension) Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global High Blood Pressure Drugs (Hypertension) Revenue by Region (2021-2026) & (USD Million)
Table 64. Global High Blood Pressure Drugs (Hypertension) Sales by Type (2016-2021e) & (K MT)
Table 65. Global High Blood Pressure Drugs (Hypertension) Sales by Type (2021-2026) & (K MT)
Table 66. Global High Blood Pressure Drugs (Hypertension) Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global High Blood Pressure Drugs (Hypertension) Revenue by Type (2021-2026) & (USD Million)
Table 68. Global High Blood Pressure Drugs (Hypertension) Price by Type (2016-2021e) & (USD/MT)
Table 69. Global High Blood Pressure Drugs (Hypertension) Price by Type (2021-2026) & (USD/MT)
Table 70. Global High Blood Pressure Drugs (Hypertension) Sales by Application (2016-2021e) & (K MT)
Table 71. Global High Blood Pressure Drugs (Hypertension) Sales by Application (2021-2026) & (K MT)
Table 72. Global High Blood Pressure Drugs (Hypertension) Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global High Blood Pressure Drugs (Hypertension) Revenue by Application (2021-2026) & (USD Million)
Table 74. Global High Blood Pressure Drugs (Hypertension) Price by Application (2016-2021e) & (USD/MT)
Table 75. Global High Blood Pressure Drugs (Hypertension) Price by Application (2021-2026) & (USD/MT)
Table 76. North America High Blood Pressure Drugs (Hypertension) Sales by Country (2016-2021e) & (K MT)
Table 77. North America High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2026) & (K MT)
Table 78. North America High Blood Pressure Drugs (Hypertension) Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America High Blood Pressure Drugs (Hypertension) Revenue by Country (2021-2026) & (USD Million)
Table 80. North America High Blood Pressure Drugs (Hypertension) Sales by Type (2016-2021e) & (K MT)
Table 81. North America High Blood Pressure Drugs (Hypertension) Sales by Type (2021-2026) & (K MT)
Table 82. North America High Blood Pressure Drugs (Hypertension) Sales by Application (2016-2021e) & (K MT)
Table 83. North America High Blood Pressure Drugs (Hypertension) Sales by Application (2021-2026) & (K MT)
Table 84. Europe High Blood Pressure Drugs (Hypertension) Sales by Country (2016-2021e) & (K MT)
Table 85. Europe High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2026) & (K MT)
Table 86. Europe High Blood Pressure Drugs (Hypertension) Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe High Blood Pressure Drugs (Hypertension) Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe High Blood Pressure Drugs (Hypertension) Sales by Type (2016-2021e) & (K MT)
Table 89. Europe High Blood Pressure Drugs (Hypertension) Sales by Type (2021-2026) & (K MT)
Table 90. Europe High Blood Pressure Drugs (Hypertension) Sales by Application (2016-2021e) & (K MT)
Table 91. Europe High Blood Pressure Drugs (Hypertension) Sales by Application (2021-2026) & (K MT)
Table 92. Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales by Region (2016-2021e) & (K MT)
Table 93. Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales by Region (2021-2026) & (K MT)
Table 94. Asia-Pacific High Blood Pressure Drugs (Hypertension) Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific High Blood Pressure Drugs (Hypertension) Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales by Type (2016-2021e) & (K MT)
Table 97. Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales by Type (2021-2026) & (K MT)
Table 98. Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales by Application (2016-2021e) & (K MT)
Table 99. Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales by Application (2021-2026) & (K MT)
Table 100. South America High Blood Pressure Drugs (Hypertension) Sales by Country (2016-2021e) & (K MT)
Table 101. South America High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2026) & (K MT)
Table 102. South America High Blood Pressure Drugs (Hypertension) Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America High Blood Pressure Drugs (Hypertension) Revenue by Country (2021-2026) & (USD Million)
Table 104. South America High Blood Pressure Drugs (Hypertension) Sales by Type (2016-2021e) & (K MT)
Table 105. South America High Blood Pressure Drugs (Hypertension) Sales by Type (2021-2026) & (K MT)
Table 106. South America High Blood Pressure Drugs (Hypertension) Sales by Application (2016-2021e) & (K MT)
Table 107. South America High Blood Pressure Drugs (Hypertension) Sales by Application (2021-2026) & (K MT)
Table 108. Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales by Country (2016-2021e) & (K MT)
Table 109. Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2026) & (K MT)
Table 110. Middle East & Africa High Blood Pressure Drugs (Hypertension) Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa High Blood Pressure Drugs (Hypertension) Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales by Type (2016-2021e) & (K MT)
Table 113. Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales by Type (2021-2026) & (K MT)
Table 114. Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales by Application (2016-2021e) & (K MT)
Table 115. Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales by Application (2021-2026) & (K MT)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. High Blood Pressure Drugs (Hypertension) Typical Distributors
Table 119. High Blood Pressure Drugs (Hypertension) Typical Customers
List of Figures
Figure 1. High Blood Pressure Drugs (Hypertension) Picture
Figure 2. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Type in 2020
Figure 3. ACEI
Figure 4. CCB
Figure 5. ARB
Figure 6. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Application in 2020
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Online Pharmacy
Figure 10. Global High Blood Pressure Drugs (Hypertension) Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 11. Global High Blood Pressure Drugs (Hypertension) Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey High Blood Pressure Drugs (Hypertension) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global High Blood Pressure Drugs (Hypertension) Sales (2016-2026) & (K MT)
Figure 32. Global High Blood Pressure Drugs (Hypertension) Production Capacity (2016-2026) & (K MT)
Figure 33. Global High Blood Pressure Drugs (Hypertension) Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. High Blood Pressure Drugs (Hypertension) Market Drivers
Figure 35. High Blood Pressure Drugs (Hypertension) Market Restraints
Figure 36. High Blood Pressure Drugs (Hypertension) Market Trends
Figure 37. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Manufacturer in 2020
Figure 38. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Manufacturer in 2020
Figure 39. High Blood Pressure Drugs (Hypertension) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 High Blood Pressure Drugs (Hypertension) Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 High Blood Pressure Drugs (Hypertension) Manufacturer (Revenue) Market Share in 2020
Figure 42. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Region (2016-2026)
Figure 43. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Region (2016-2026)
Figure 44. North America High Blood Pressure Drugs (Hypertension) Revenue (2016-2026) & (USD Million)
Figure 45. Europe High Blood Pressure Drugs (Hypertension) Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific High Blood Pressure Drugs (Hypertension) Revenue (2016-2026) & (USD Million)
Figure 47. South America High Blood Pressure Drugs (Hypertension) Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa High Blood Pressure Drugs (Hypertension) Revenue (2016-2026) & (USD Million)
Figure 49. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2016-2026)
Figure 50. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2016-2026)
Figure 51. Global High Blood Pressure Drugs (Hypertension) Price by Type (2016-2026) & (USD/MT)
Figure 52. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2016-2026)
Figure 53. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2016-2026)
Figure 54. Global High Blood Pressure Drugs (Hypertension) Price by Application (2016-2026) & (USD/MT)
Figure 55. North America High Blood Pressure Drugs (Hypertension) Sales Market Share by Country (2016-2026)
Figure 56. North America High Blood Pressure Drugs (Hypertension) Revenue Market Share by Country (2016-2026)
Figure 57. North America High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2016-2026)
Figure 58. North America High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2016-2026)
Figure 59. Europe High Blood Pressure Drugs (Hypertension) Sales Market Share by Country (2016-2026)
Figure 60. Europe High Blood Pressure Drugs (Hypertension) Revenue Market Share by Country (2016-2026)
Figure 61. Europe High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2016-2026)
Figure 62. Europe High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific High Blood Pressure Drugs (Hypertension) Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2016-2026)
Figure 67. South America High Blood Pressure Drugs (Hypertension) Sales Market Share by Country (2016-2026)
Figure 68. South America High Blood Pressure Drugs (Hypertension) Revenue Market Share by Country (2016-2026)
Figure 69. South America High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2016-2026)
Figure 70. South America High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa High Blood Pressure Drugs (Hypertension) Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source

---